Advantest (6857) Q4 2025 (Q&A) earnings summary

Executive summary

• Achieved record highs in sales, operating income, and net income for FY24, driven by robust tester demand for AI and high-performance semiconductors, with overseas sales accounting for 98.0% of total net sales.

• Strong performance was supported by sustained demand in AI and HPC devices, with no significant one-time yield effects impacting test capacity requirements.

• Implemented strategic initiatives under the third mid-term management plan, focusing on market growth, new business expansion, operational excellence, and sustainability.

• First half of the fiscal year expected to be stronger than the second half, with some moderation but no major decline anticipated.

• Optimism for 2026 growth due to next-generation HPC devices and increased activity from cloud service providers and Custom ASIC partners.

Financial highlights

• FY24 sales reached JPY 779.7B, up 60.3% year-over-year; operating income rose to JPY 228.2B (2.8x YoY), and net income was JPY 161.2B (2.6x YoY); gross margin improved to 57.1%.

• SoC tester gross margin reached 60% in the March quarter, attributed to a favorable product mix and high-margin upgrades; sustaining this level is unlikely as margins will fluctuate.

• Q4 FY24 sales were JPY 232.3B, up 6.5% sequentially and 71.1% year-over-year; Q4 net income was JPY 40.0B.

• Basic earnings per share increased to ¥218.67 from ¥84.45 year-over-year (adjusted for share split).

• Free cash flow for FY24 was JPY 243.8B.

Outlook and guidance

• FY2025 forecast: net sales of ¥755.0 billion (-3.2% YoY), operating income of ¥242.0 billion (+6.1%), and net income of ¥179.0 billion (+11.1%), with AI-related tester demand expected to remain high.

• Revenue guidance for fiscal March 2026 is slightly up, with a cautious approach due to macroeconomic uncertainties and limited visibility beyond the first half.

• Guidance is based on the midpoint of calendar 2025 tester time, with no significant customer behavioral changes observed due to tariffs or macro uncertainty.

• First and second quarters of the fiscal year are expected to be flat, supported by strong bookings and pipeline.

• R&D expenses and capital expenditure to increase modestly in FY25.